Schema showing the duration of the abciximab infusion (grey section) following the bolus in each of the patients studied. The moment at which PTCA was performed is indicated, as is the time at which patient 3 underwent CABG. The vertical arrows show the times (h) at which samples were taken for EM and platelet function testing. The point at which abciximab therapy started is considered as time zero.